A novel CDK4/6 inhibitor combined with irradiation demonstrates potent anti-tumor efficacy in diffuse midline glioma

被引:0
作者
Pengcheng Zuo
Yaopeng Li
Tantan Wang
Xingyu Lin
Zhen Wu
Junting Zhang
Xuebin Liao
Liwei Zhang
机构
[1] Capital Medical University,Department of Neurosurgery, Beijing Tiantan Hospital
[2] China National Clinical Research Center for Neurological Diseases (NCRC-ND),School of Pharmaceutical Sciences, Peking
[3] Tsinghua University,Tsinghua Center for Life Sciences, Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology (Ministry of Education)
[4] Capital Medical University,Advanced Innovation Center for Human Brain Protection, Beijing Tiantan Hospital
[5] Zhuhai Yufan Biotechnologies Co.,undefined
[6] Ltd,undefined
来源
Journal of Neuro-Oncology | 2023年 / 163卷
关键词
Diffuse midline glioma; H3 K27-altered; CDK4/6 inhibitor; Anti-tumor efficacy; Blood–brain barrier; Radiotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:159 / 171
页数:12
相关论文
共 327 条
[1]  
Vanan MI(2015)DIPG in children—what can we learn from the past? Front Oncol 5 237-25
[2]  
Eisenstat DD(2019)Preclinical therapeutic targets in diffuse midline glioma Drug Resist Updates 44 15-4784
[3]  
Meel MH(2001)Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo Mol Cell Biol 21 4773-475
[4]  
Kaspers GJL(2017)CDK4/6 inhibition triggers anti-tumour immunity Nature 548 471-537e525
[5]  
Hulleman E(2017)Integrated molecular meta-analysis of 1000 pediatric high-grade and diffuse intrinsic pontine glioma Cancer Cell 32 520-3500
[6]  
Ezhevsky SA(2018)Combined use of CDK4/6 and mTOR inhibitors induce synergistic growth arrest of diffuse intrinsic pontine glioma cells via mutual downregulation of mTORC1 activity Cancer Manage Res 10 3483-24
[7]  
Ho A(2013)PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma PLoS ONE 8 e77639-179
[8]  
Becker-Hapak M(2019)Authors' reply to “Translating palbociclib to the clinic for DIPG—what is truly achievable?” EBioMedicine 45 23-1438
[9]  
Davis PK(2019)Potent anti-tumor efficacy of palbociclib in treatment-naïve H3.3K27M-mutant diffuse intrinsic pontine glioma EBioMedicine 43 171-5657
[10]  
Dowdy SF(2004)Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts Mol Cancer Ther 3 1427-829